Venous Distension in Patients With Aneurysmatic Arterial Disease

Sponsor
Kantonsspital Baselland Bruderholz (Other)
Overall Status
Completed
CT.gov ID
NCT02867501
Collaborator
(none)
98
10.9

Study Details

Study Description

Brief Summary

The aim of the study is to assess if venous distension in patients with aneurysmatic arteriopathy is higher compared to patients with peripheral arterial occlusive disease (PAOD) and in controls.

Detailed Description

Patients with aortic aneurysm and patients with PAOD and Controls will be investigated in the following manner: Duplexsonography with assessment of the arterial diameters in the aorta and leg arteries. Duplexsonography with assessment of venous reflux in proximal and deep veins of both legs Duplexsonography testing of venous distension in the common femoral vein, the great saphenous vein and the femoral vein.

Study Design

Study Type:
Observational
Actual Enrollment :
98 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Venous Distension in Patients With Aneurysmatic Arterial Disease Compared to the Venous Distension in Patients With Arterial Occlusive Disease
Study Start Date :
May 1, 2016
Actual Primary Completion Date :
Mar 28, 2017
Actual Study Completion Date :
Mar 28, 2017

Arms and Interventions

Arm Intervention/Treatment
Aneurysmatic disease

Patients with dilatative arteriopathy (DA) the aortic diameter must be > 3 cm or the popliteal artery diameter > 1.5 cm

Peripheral arterial occlusive disease

Patients with arterial occlusive disease (PAOD) defined with an Ankle brachial index (ABI) < 0.9 and positive criteria in the Edinburgh questionnaire.

Healthy

Control group of age matched persons without PAOD (ABI > 0.9) and without DA.

Outcome Measures

Primary Outcome Measures

  1. Venous distension of > 27% in patients with aneurysmatic arterial disease [one year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients with dilatative arteriopathy (DA) the aortic diameter must be > 3 cm or the popliteal artery diameter > 1.5 cm

  • Patients with arterial occlusive disease (PAOD) defined with an Ankle brachial index (ABI) < 0.9 and positive criteria in the Edinburgh questionnaire

  • Patients able to give informed consent

  • Control group of age matched persons without PAOD (ABI > 0.9) and without DA

Exclusion Criteria:
  • Impossibility to stand

  • Diabetes

  • No given informed consent

  • Persons and patients < 18 years old

  • Acute deep venous thrombosis

  • History of deep venous thrombosis

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Kantonsspital Baselland Bruderholz

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Janis Christian Bartelt, intern, Kantonsspital Baselland Bruderholz
ClinicalTrials.gov Identifier:
NCT02867501
Other Study ID Numbers:
  • 2016-00375
First Posted:
Aug 16, 2016
Last Update Posted:
Apr 4, 2017
Last Verified:
Mar 1, 2017
Keywords provided by Janis Christian Bartelt, intern, Kantonsspital Baselland Bruderholz
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 4, 2017